American Cannabis News

Cannabis Stocks Extend Decline in November – New Cannabis Ventures

Published

3 months ago

November 29, 2025

admin

Cannabis Stocks Rocketed Higher in August – New Cannabis Ventures

Hemp stocks, as measured by the Global Hemp Stock Index, were quite volatile in 2024 and have been in 2025 as well. The index fell 7.5% in December last year to close 15.2% lower for the year, and it was also a poor start to 2025. It hit a new all-time high of 4.97 on the last day of March, before falling back in early April. The index gained 11.5% in April, but ended the second quarter from there, closing at 5.02. Q3 was strong with increases in July and August, and September, which started with a pullback, ended with another increase before pulling back on the last day. The index ended September with only a small decline before falling in October. It retreated sharply again in November, falling 11.0% to 6.08.

After collapsing 21.8% in late 2024 to 6.88 in Q4, the index fell heavily in Q1 and then marginally in Q2. The global hemp stock index, which now has 28 members, fell 27% year-to-date in June. After a 53.0 percent rally in the third quarter, the index increased by 11.6 percent compared to last year. It is now down 20.8% in Q4 and down 11.6% year-over-year.

Since its peak in February 2021, the global hemp stock index is down 93.4% from a closing high of 92.48.

The top 3 names were all up more than 11% in November;

Each of these stocks has been significantly upgraded year-over-year, and Q4 earnings were positive for each of them, especially Jazz Pharma and Village Farms.

November’s 3 weakest names are all down more than 39%;

All of these stocks are down significantly year-over-year, and Q4 has been brutal for each.

We will summarize the performance of the index again in a month. In April, we historically combined the two articles, and we update here the other indexes that New Cannabis Ventures continues to maintain: the American Cannabis Operator Index, the Ancillary Cannabis Index, and the Canadian Cannabis LP Index.

American Hemp Operator Index

The ACOI fell again in November, falling 24.9% to 9.17. It rose 123.6% to 12.99 in Q3 and is now up 9.7% year-to-date from 8.36. The large AdvisorShares Pure US Cannabis ETF ( MSOS ) fell 8.7%.

The strongest performer in November was Glass House Brands (OTC: GLASF ) (NEO: GLAS.AU ), which fell 13.5%. The weakest, Cresco Labs (OTC: CRLBF ) (CSE: CL ), fell 36.8%.

The index will have eight members in December with the removals of Ascend Wellness (OTC: AAWH ) and Vireo Health (OTC: VREOF ).

Auxiliary cannabis index

Ancillary commodities lost 1.7% in November as the index fell to 10.83. The index, which rose 14.5% to 12.72 in Q3, now fell 14.9% in Q4. It is down 21.4% year-to-date from 13.77 in 2025.

The strongest stock in November was Turning Point Brands, which rose 11.4%. The weakest, WM Technology, fell by 19.3%.

In December, the index will have the same eight members.

Canadian Hemp LP Index

Canadian LPs fell 15.0% in November as the index fell to 56.00. The index, which increased by 78.4% in the third quarter, reaching 73.56. now down 23.9% in Q4 but up 11.8% in 2025 from 50.11 year to date.

The strongest Canadian LP in November was Organigram Holdings (TSX: OGI ), which rose 0.4%, leaving it as the sole gainer on the index. Simply Solventless (TSXV: HASH ) was the weakest, down 39.1%.

In December, the index will have the same thirteen members.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

In this article.

Cresco Labs, CRLBF:, blue, glass house brands, HASH:, Jazz, Jazz Pharmaceuticals, maps, BREAD, Organigram Holdings, shf holdings, shfs, Simply unsolvable, Tilray brands, TLRY:, TPB:, Revolving brands, VFF:, Farms, wm technology

Related Topics:Cannabis Decline Extend November Stocks Ventures

Up Next

Cannabist to Sell Virginia Assets to Curaleaf – New Cannabis Ventures

Don't Miss

Be Careful With Canadian LPs – New Cannabis Ventures

AdvisorShares Pure US Cannabis ETF

Cannabis Stocks Are Sinking – New Cannabis Ventures

Published

12 hours ago

February 12, 2026

admin

Cannabis Stocks Are Sinking – New Cannabis Ventures

You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.

friends,

The Global Hemp Stock Index closed 2/11 at 5.69, down 3.4% in February and 13.7% year-to-date in 2026. Since April 30, 2024, it has fallen by 51.4%. The index peaked at 92.48 five years ago and has since declined 93.9%.

Many are keeping an eye on the AdvisorShares Pure US Cannabis ETF (NYSE Arca: MSOS ) and it is down 16.1% so far in 2026, and since 4/30/24 the decline has been a massive 64.8% to its current $3.96. That’s only slightly higher than $3.81, where it ended 2024, and well above the all-time low of $2.02 set in April of last year. The ETF currently has about 2/3 of its portfolio in just three MSOs. Including four other positions above 5%, the top 7 represent 93.6% of MSOS.

Cannabis stocks are clearly under pressure. The 27 stocks in the Global Hemp Stock Index were mostly lower, although two of the stocks rose more than 15%, Scotts Miracle-Gro and Turning Point Brands. Neither of these two companies exclusively serve the hemp industry. 7 stocks fell by more than 20%, three of which fell by more than 44%.

A few companies reported quarters that ended 12/31, but most of the companies in the index had their year ending and will report them later this month. I’ll share a preview before then. I don’t think financial statements are what it will take to make things right for hemp stocks. Instead, it requires a rearrangement that will result in termination 280E taxwhich I discuss in this weekly newsletter from late 2022. The good news is that it is still potentially alive. I continue to suggest that it should not be assumed that this will happen. It should happen, and it would be good if it happened. Good luck to all consumers, medical patients, industry workers and investors.

Sincerely,

Alan:

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 2 weeks.

Exclusives

Cannabis sales fell in January

Hemp stocks are off to a bad start in 2026

Illinois provides another cannabis update

Capital increase

Canadian LP Decibel extends debt

Trulieve owes another $60 million

Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.

American Cannabis Coverage by State

Cannabis Sales Slipped in January – New Cannabis Ventures

Published

1 week ago

February 4, 2026

admin

Cannabis Sales Were Soft Again – New Cannabis Ventures

On February 3, 2026 at 8:42 PM

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s 15-state monthly cannabis sales data.

In January, cannabis sales decreased sequentially by 3.1%. In this review, we break down the results by state, starting with the western markets and then ending with the eastern markets. Overall, the BDSA estimates sales in 15 markets totaled $2.07 billion in January, up 4.6 percent from a year earlier. BDSA updated its Illinois numbers after the state recently changed the way it counts sales.

Western markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In December, annual growth was negative in 4 states. Growth in each of these states fell in succession.

Eastern markets

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio and Pennsylvania. Annual growth in December ranged from -3.1% in Missouri to +37.6% in New York. Ohio began using adults in August, spurring growth. Note that Florida and Pennsylvania are medical markets only. On a daily basis, sequential gains declined in eight markets. Annual growth was negative in both markets and sharp in both states. We warned of a potential slowdown in Florida despite strong dispensary and unit volume growth due to competitive pressure.

For readers interested in a deeper look hemp markets in these fifteen states and more, including segmentation by additional product categories, brand and product details, longer history and segmentation by product attributes, learn how BDSA Solutions can give you access to actionable data and analytics.

In this article.

Arizona, bdsa, California, cannabis data analysis, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, New York, Ohio, Oregon, Pennsylvania

4Front

Illinois Provides Another Cannabis Update – New Cannabis Ventures

Published

2 weeks ago

February 1, 2026

admin

Illinois Cannabis Data Change Suggests Much Lower Sales – New Cannabis Ventures

February 1, 2026 at 3:27 p.m

Illinois released sales figures for two months on Friday. The last time it released the data in November, the state did a major review of historical sales after a long delay, and it was updated to October. The previous report was for Cannabis for adults in May. The November document explained that the lack of data was due to the Metrc transition. “Sales tracking features in Metrc help retailers more accurately and reliably report actual sales, including all discounts and promotions at checkout. A careful review of past data shows that some initial discount prices were collected in previous months.” Here is the updated data until the end of 2025.

Statewide adult cannabis sales rose 5.6% sequentially to $116.6 million in December, up 2.2% on the day. Year-on-year growth was -23.9%, a slight improvement from November’s -26.1% growth. Here is a chart of adult sales over time:

After growing 106% in 2021, 13% in 2022 and 5% in 2023, annual sales for adults are set to grow 5.4% to $1.72 billion in 2024. In 2025, they decreased by 12.5% to $1.51 billion, which was lower than the total in 2022.

There hasn’t been an update from the state on medical cannabis in a while. The state exempts the sale separately from its medical plan, and April issue showed that sales fell 1.6% sequentially to $19.7 million, down 13.2% year over year.